Shenyang Dongxin Pharmaceutical Co., Ltd. Sustainability Profile
Shenyang Dongxin Pharmaceutical Co., Ltd., commonly referred to as Dongxin Pharma, is a prominent player in the pharmaceutical industry, headquartered in Shenyang, China. Established in 1995, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, particularly in the fields of antibiotics and cardiovascular medications. With a strong operational presence across various regions in China, Dongxin Pharma is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of generic drugs and active pharmaceutical ingredients (APIs), distinguished by their efficacy and safety. Dongxin Pharma has achieved notable recognition in the market, positioning itself as a trusted name in the pharmaceutical sector, dedicated to improving healthcare outcomes.
DitchCarbon Score
How does Shenyang Dongxin Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shenyang Dongxin Pharmaceutical Co., Ltd.'s score of 20 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shenyang Dongxin Pharmaceutical Co., Ltd.'s reported carbon emissions
Shenyang Dongxin Pharmaceutical Co., Ltd., headquartered in CN, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Shenyang Dongxin Pharmaceutical may not have established formal commitments to address carbon emissions or climate change initiatives at this time. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Shenyang Dongxin to consider developing and disclosing their climate strategies to align with global standards and expectations.
How Carbon Intensive is Shenyang Dongxin Pharmaceutical Co., Ltd.'s Industry?
How Carbon Intensive is Shenyang Dongxin Pharmaceutical Co., Ltd.'s Location?
Shenyang Dongxin Pharmaceutical Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shenyang Dongxin Pharmaceutical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
